Grafta Nanotech Income Statement

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	0.03	0.1	-
Revenue Growth	-	-	-
Cost of Revenue	0.02	0.03	-
Gross Profit	0.01	0.06	-
Selling, General & Admin	0.69	0.58	0.64
Research & Development	0.15	0.13	0.09
Operating Expenses	1.39	1.25	1.27
Operating Income	-1.38	-1.19	-1.27
Interest Expense	-0.11	-0.25	-0.69
Currency Exchange Gain (Loss)	-0	-0	0
Other Non Operating Income (Expenses)	-0.03	-0	-0
EBT Excluding Unusual Items	-1.52	-1.44	-1.96
Gain (Loss) on Sale of Assets	-	-	-0.02
Other Unusual Items	3.93	3.93	-
Pretax Income	2.41	2.49	-1.99
Net Income	2.41	2.49	-1.99
Net Income to Common	2.41	2.49	-1.99
Net Income Growth	-	-	-
Shares Outstanding (Basic)	58	54	51
Shares Outstanding (Diluted)	58	54	51
Shares Change	-	6.14%	-
EPS (Basic)	0.04	0.05	-0.04
EPS (Diluted)	0.04	0.05	-0.04
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-0.78	-0.61	-0.41
Free Cash Flow Per Share	-0.01	-0.01	-0.01
Gross Margin	32.70%	65.22%	-
Operating Margin	-4019.03%	-1248.17%	-
Profit Margin	7000.57%	2604.07%	-
Free Cash Flow Margin	-2281.53%	-637.79%	-
EBITDA	-1.02	-0.79	-0.87
D&A For EBITDA	0.37	0.4	0.4
EBIT	-1.38	-1.19	-1.27